College of Life Sciences, Henan University, Jin Ming Avenue, Kaifeng, Henan, 475004, China.
Department of Chemistry & Biological Engineering, University of Science & Technology Beijing, Beijing, 100083, P. R. China.
Small. 2017 May;13(20). doi: 10.1002/smll.201603966. Epub 2017 Mar 31.
Innovative nanoparticles hold promising potential for disease therapy as drug delivery systems. For brain-disease therapy, a drug delivery system that can sustainably control drug-release and monitor fluorescence of the drug cargos is highly desirable. In this study, a light-traceable and intracellular microenvironment-responsive drug delivery system was developed based on the combination of glutathione-responsive autoflurescent nanogel, dendrimer-like mesoporous silica nanoparticles, and gold nanoparticles. The resulting hybrid nanoparticles represent a new class of delivery system that can efficiently load, transport, and control multistage-release of sulfydryl-containing drugs into neurons, with light-traceable monitoring for future brain-disease therapy.
创新型纳米颗粒作为药物传递系统,在疾病治疗方面具有广阔的应用前景。对于脑部疾病的治疗,人们非常希望有一种药物传递系统,能够持续控制药物释放并监测药物载体的荧光。本研究基于谷胱甘肽响应型自发荧光纳米凝胶、树状大分子介孔硅纳米粒子和金纳米粒子的结合,开发了一种光可追踪的细胞内微环境响应型药物传递系统。所得的杂化纳米粒子代表了一类新型的输送系统,能够高效地装载、输送和控制含巯基药物的多阶段释放进入神经元,具有光可追踪监测功能,可用于未来的脑部疾病治疗。